Syntone Ventures, 10% Owner: Outlook Therapeutics OTLK Buy · Filed 24/04/17

Trade details

Type: Insider buy
Shares · price: 714,286 sh · price in footnote
Held after: 1,705,438 sh
Stock: Outlook Therapeutics OTLK
Person: Syntone Ventures10% Owner
Trade date: 24/04/15
Filed: 24/04/17
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 1 insiders
Holding change: +72.1%

Outlook Therapeutics trades, last 26 weeks

What else happened in Outlook Therapeutics around then

Filed or reported within 30 days of the trade day · 24/03/16~24/05/15

Syntone Ventures's recent trades

No other trades yet.

Syntone Ventures, 10% Owner — bought 714,286 sh of Outlook Therapeutics OTLK · price in footnote | Whalegun